Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Piroxicam Taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
Piroxicam Betacyclodextrine Manufacturers in India Suppliers Piroxicam Betacyclodextrine Exporters Distributors Piroxicam Betacyclodextrine api active pharmaceuticals ingredients Piroxicam Betacyclodextrine manufacturers Side Effects bulk drugs raw material Piroxicam Betacyclodextrine companies Side Effects Importers Piroxicam Betacyclodextrine Piroxicam Betacyclodextrine Exporters Piroxicam Betacyclodextrine exporters FDA Piroxicam Betacyclodextrine DMF Symptoms Generic Taj Pharmaceuticals Ltd. active pharmaceutical ingredients suppliers pharmaceutical Piroxicam Betacyclodextrine manufacturing pharmaceutical drugs pharmaceutical intermediates Piroxicam Betacyclodextrine pharmaceutical chemicals pharmaceutical raw materials Piroxicam Betacyclodextrine active pharmaceutical ingredients Piroxicam Betacyclodextrine committee active pharmaceutical ingredients manufacturer Piroxicam Betacyclodextrine Active Pharmaceutical Ingredients manufacturer Piroxicam Betacyclodextrine exporter drug ingredients pharmaceuticals Pharmaceuticals API Manufacturer Piroxicam Betacyclodextrine, Piroxicam Betacyclodextrine manufacturer India, Piroxicam Betacyclodextrine product, Piroxicam Betacyclodextrine products, Api preparation, Certificate of Analysis API manufacturer product, Piroxicam Betacyclodextrine anti ulcer product, Certificate of Origin COA Piroxicam Betacyclodextrine COS Piroxicam Betacyclodextrine, pharmaceutical generic, pharmaceutical drug, medical, Piroxicam Betacyclodextrine pharma healthcare, pharma patents, contract MSDS manufacturing Trader Piroxicam Betacyclodextrine pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Piroxicam Betacyclodextrine expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Piroxicam Betacyclodextrine DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Piroxicam Betacyclodextrine ingredients, api, HIV Piroxicam Betacyclodextrine, tablets, capsules, syrup & protein Piroxicam Betacyclodextrine powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Piroxicam Betacyclodextrine gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Piroxicam Betacyclodextrine WHO, UKMHRA Approval
   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Pioglitazone  Taj API










 

 















 

 

 

 

 

HOME >> API >> API List 3 >> Piroxicam Betacyclodextrine

Piroxicam Betacyclodextrine CAS Registry Number 96684-40-1

Molecular Structure

Piroxicam Betacyclodextrine Molecular Formula C20H21N3O7S

Piroxicam Betacyclodextrine

Molecular Formula C20H21N3O7S

Molecular Weight 447.46

CAS Registry Number
96684-40-1

Piroxicam-beta-cyclodextrin is a complex of the established nonsteroidal antiinflammatory drug (NSAID) piroxicam and an inert cyclic macromolecule, beta-cyclodextrin. In clinical trials in patients with rheumatic diseases or pain arising from other conditions, it was as effective an analgesic as standard piroxicam, and showed a faster onset of action on the first day of treatment. In short term pharmacodynamic studies in healthy volunteers, piroxicam-beta-cyclodextrin was equivalent to or tended to show less gastrointestinal mucosal toxicity than standard piroxicam, as assessed by endoscopy and faecal blood loss. However, no data are available on its comparative gastrointestinal mucosal effects from long term clinical trials using similar measures. Preliminary findings from a clinical study suggest piroxicam-beta-cyclodextrin caused fewer gastroduodenal lesions than tenoxicam. As with other NSAIDs, the majority of adverse events associated with piroxicam-beta-cyclodextrin in clinical trials were gastrointestinal in origin, with epigastric pain, heartburn and nausea the most common. Thus, piroxicam-beta-cyclodextrin is an effective agent in patients with rheumatic diseases or other pain states. When rapid analgesia is required in the initial treatment of acute pain, the faster onset of action of piroxicam-beta-cyclodextrin may be an advantage over the parent compound; however, this is unlikely to be important during long term therapy. The results of further long term trials are awaited before firm conclusions can be reached regarding the gastrointestinal tolerability of piroxicam-beta-cyclodextrin compared with that of standard piroxicam and other NSAIDs.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo
 

Piroxicam Betacyclodextrine

Api Manufacturer,Export,Supplies,Manufacturing in India

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

 

    Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.